An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (19)
  • Podcast (13)
  • Publications (652)
  • Training (6)
  • User case (13)
  • User meeting (21)
  • Webinar (119)
  • White paper (8)
Key content topics
Key audience
  • Newcomers (6)
Top cancer treatments
  • Brain and CNS (88)
  • Breast (59)
  • Gastro-intestinal (125)
  • Genito-urinary (51)
  • Gynecological (7)
  • Head and neck (133)
  • Hodgkin and Non-Hodgkin lymphoma (16)
  • Ocular (12)
  • Pediatric (100)
  • Reirradiation (12)
  • Sarcomas (18)
  • Thoracic (91)

Optimizing radiotherapy strategies for skull base chordoma: a comprehensive meta-analysis and systematic review of treatment modalities and outcomes.

30/10/2024
/ Publications

This meta-analysis from Brazil included 32 studies that reported outcomes of different radiation modalities for skull base chordoma. The 5-year OS findings were...

Current Status and Future Directions of Proton Therapy for Head and Neck Carcinoma.

30/10/2024
/ Publications

A narrative review by the CNAO group on safety and efficacy of PT compared to photon RT for nasopharyngeal cancer (NPC) and oropharyngeal cancer (OPC). For NPC...

Long-term outcomes after particle radiation therapy in patients with nasopharyngeal adenoid cystic carcinoma.

30/10/2024
/ Publications

This study from China reported treatment results of 26 patients with nasopharyngeal adenoid cystic carcinoma (NACC) treated with IMPT. With a median follow-up...

Long-Term Outcomes Following Definitive or Adjuvant Proton Radiotherapy for Adenoid Cystic Carcinoma.

30/10/2024
/ Publications

This study from the Jacksonville group reported treatment outcomes of 56 patients with de novo, nonmetastatic ACC of the head and neck treated with definitive...

Proton and carbon ion radiotherapy for operable early-stage lung cancer; a prospective nationwide registry.

30/10/2024
/ Publications

This registry study from Japan reported outcomes of 274 patients with operable lung cancer treated with proton (n=138, 50 %) and carbon ion (n=136, 50 %)...

Proton Beam Therapy for Treating Patients with Hepatocellular Carcinoma with Major Portal Vein Tumor Invasion: A Single Center Retrospective Study.

30/10/2024
/ Publications

This study from Japan reported favorable results of PBT in treatment of 116 patients with hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT...

Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma.

30/10/2024
/ Publications

This multicenter study led by the MGH group retrospectively analyzed 96 patients with unresectable intrahepatic cholangiocarcinoma (ICC) treated with...

Proton Beam Radiotherapy as a Curative Alternative to Radiofrequency Ablation for Newly Diagnosed Hepatocellular Carcinoma.

30/10/2024
/ Publications

This study by the group from Samsung Medial Center, Korea, compared the oncological outcomes of 323 patients with newly diagnosed hepatocellular carcinoma (HCC)...

Comparing 90-Day Postoperative Mortality After Neoadjuvant Proton-Based Versus Photon-Based Chemoradiotherapy for Esophageal Cancer.

30/10/2024
/ Publications

Ninety-day mortality (90DM) is an important measure of the postoperative (nononcologic) outcome as proxy of quality-of-care. This study by the MD Anderson group...

Quality Assurance for Advanced PT Delivery

15/10/2020
/ User Meeting
/
Quality assurance

During this event replay, IBA experts will share with you on the latest advances in the...

Pagination

  • Previous page ‹
    • Page 3
    • Current page 4
    • Page 5
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies